According to research, the immunotherapy drug teplizumab delays the onset of type 1 diabetes by 2 years to 2 years in people at high risk. Source of shared Link

A large European study now suggests that many diagnoses of cirrhosis and liver cancer come too late, and that diabetes might be an independent risk factor. Source of shared Link